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Introduction
Appropriate reference intervals are essential to 
clinicians when interpreting laboratory results on 
thyroid hormones.1 However, current reference 
intervals for total thyroxine (TT4), total triiodo-
thyronine (TT3), free thyroxine (FT4), and free 
triiodothyronine (FT3), when measured by 
immunoassays, are method-dependent because 
of the between-method variability.1–3 Working 
groups from the International Federation of 
Clinical Chemistry (IFCC) have shown that the 
difference between immunoassays can affect 
establishing universal reference intervals that 
would apply across methods,1 and, therefore, 
could negatively impact the clinical utility of 
immunoassays for thyroid hormones.
Measurement of thyroid hormones by isotope-
dilution liquid chromatography/tandem mass 
spectrometry (ID-LC-MS/MS) offers superior 
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Abstract
Background: There has been a wide range of reference intervals proposed in previous 
literature for thyroid hormones due to large between-assay variability of immunoassays, as 
well as lack of correction for collection time. We provided the diurnal reference intervals for 
five thyroid hormones, namely total thyroxine (TT4), total triiodothyronine (TT3), free thyroxine 
(FT4), free triiodothyronine (FT3), and reverse T3 (rT3), measured in serum samples of healthy 
participants using a liquid chromatography/tandem mass spectrometry (LC-MS/MS) method.
Methods: Couplet serum samples (a.m. and p.m.) were collected from 110 healthy females 
and 49 healthy males. Healthy volunteers were recruited from four participating centers 
between 2016 and 2018. Measurements of thyroid hormones were obtained by LC-MS/MS 
analysis.
Results: Our study revealed significant uptrend in AM to PM FT4 (p < 0.0001) samples, 
downtrend in AM to PM TT3 (p = 0.0004) and FT3 samples (p < 0.0001), and AM to PM uptrend 
in rT3 samples (p < 0.0001). No difference was observed for TT4 between AM and PM. No 
significant sex differences were seen for any of the five thyroid hormones.
Conclusion: When diagnosing thyroid disorders, it is important to have accurate measurement 
of thyroid hormones, and to acknowledge the diurnal fluctuation found, especially for FT3. Our 
study highlights the importance of standardization of collection times and implementation of 
LC-MS/MS in thyroid hormone measurement.
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specificity and accuracy compared with immuno-
assays, and therefore serves as the reference meas-
urement procedure.1,4–6 Whereas immunoassay 
measurements of free thyroid hormones are 
affected by thyroid hormone binding proteins 
such as thyroxine binding globulin (TBG), and, 
to a lesser degree, prealbumin and albumin, the 
interference is minimal when measured by 
LC-MS/MS after these proteins are removed by 
either ultrafiltration or equilibrium dialysis.7–9 In 
addition, FT4 showed a far better inverse log-
linear relationship with thyroid stimulating hor-
mone (TSH) when measured by LC-MS/MS 
than by immunoassay,7,8,10 suggesting inadequate 
measurement by immunoassays. This manuscript 
provides a comprehensive study to establish 
thyroid hormone reference intervals using 
LC-MS/MS.
TSH shows significant diurnal variation, and this 
could result in misclassification of patients if 
time-dependent (a.m. versus p.m.) reference 
intervals were not applied.11,12 Similarly, diurnal 
variation was also seen in thyroid hormones, and 
especially in FT3.13–15 Prior studies on reference 
intervals of thyroid hormones, however, have not 
corrected for collection time and this can poten-
tially be one of the many reasons for the wide 
range in reference intervals.1 This study provides 
the diurnal reference intervals for five thyroid 
hormones, namely TT4, TT3, FT4, FT3, and 
reverse T3 (rT3), measured in serum samples of 
healthy participants using the LC-MS/MS 
method.
Methods
Subjects and specimens
Subjects included 159 healthy volunteers; all 
were included after informed written consent was 
obtained. Healthy participants were determined 
by screening assessments including a detailed 
medical history, absence of medication or supple-
ments use, and physical examination by a medical 
provider. We excluded participants with family 
history of thyroid disorders, smoking history, as 
well as measurable thyroid peroxidase (TPO) 
antibody values (⩾10.0 IU/ml on Siemens 
IMMULITE® 2000), which is associated with 
autoimmune hypothyroidism and Graves’ dis-
ease.16 Participants with a sample volume insuffi-
cient for TPO antibody measurement were also 
excluded. These volunteers lived in the United 
States, South Africa, and Turkey, where iodine 
intake is generally sufficient.17–19
Serum samples were collected at four sites, which 
included the National Institutes of Health (NIH, 
US), Georgetown University (US), Walter Sisulu 
University (South Africa), and Uludag University 
(Turkey) between 2016 and 2018. Morning sam-
ples were collected between 6:00 and 9:00 a.m., 
and paired evening samples were collected 
between 6:00 and 9:00 p.m. All blood sampling 
was carried out by professional phlebotomists, 
collected in preservative/gel-free serum specimen 
collection tubes, and kept chilled and centrifuged 
within 1 h of collection to separate serum. 
Samples were stored at −80°C until assayed by 
LC-MS/MS. All samples in this study were 
approved by the institutional review boards at 
NIH (protocol 93-CC-0094) and Georgetown 
University (Pro0000007-01).
LC-MS/MS
FT3 and FT4 were separated from protein-bound 
hormones by ultrafiltration at 37°C, followed by 
measurement using an ABSCIEX Triple-
Quad-6500 isotope dilution LC-MS/MS System 
(AB Sciex, Concord, ON, CA) as previously 
described.7,20 TT3, TT4, and rT3 were meas-
ured by atmospheric pressure photoionization 
LC-tandem MS using the Agilent 6460 triple-
quadrupole mass spectrometer coupled to the 
Agilent 1200 Infinity Series HPLC (Agilent 
Technologies, Santa Clara, CA, USA) as previ-
ously described.7,8 Complete method validation 
details have been published previously20; the 
intra-assay coefficients of variation are <9% for 
all five analytes. Inter-laboratory quality and 
accuracy of sample analysis was assessed prior 
to the study with the Mayo Clinic (Rochester, 
MN), NMS Laboratories (Willow Grove, PA) 
and Children’s National Medical Center 
(Washington DC).
Statistical analysis
Statistical analyses were performed using 
GraphPad Prism, version 8. Shapiro–Wilk nor-
mality test was used to assess distribution of thy-
roid hormone concentration as well as distribution 
of the data following log transformation. For 
Shapiro–Wilk test, alpha = 0.05 was chosen and 
the p value was compared with alpha to determine 
the passing of lognormality test. Difference 
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between a.m. and p.m. results within the same 
individual was assessed by Wilcoxon matched-
pairs test. Reference intervals for all five thyroid 
hormones were obtained using the percentile 
approach. Significant values were determined at 
p < 0.05.
Results
The number of samples obtained for establishing 
the reference intervals for TT4, TT3, and rT3 
was 159 pairs (n = 110 female; n = 49 male); due 
to sample volume shortage, the number was 146 
pairs for FT4 (n = 101 female; n = 45 male) and 
141 pairs for FT3 (n = 99 female; n = 42 male). 
Our study revealed significant uptrend in a.m. to 
p.m. FT4 samples (p < 0.0001), downtrend in 
a.m. to p.m. TT3 (p = 0.0004) and FT3 samples 
(p < 0.0001), and a.m. to p.m. uptrend in rT3 
samples (p < 0.0001; Figure 1). No difference 
was observed for TT4 (p = 0.1978) between a.m. 
and p.m. Thyroid concentrations between the 
females and males were also compared. However, 
no significant sex differences were seen for any of 
the five thyroid hormones.
All five analytes (TT4, TT3, FT4, FT3, rT3) 
showed non-Gaussian distribution, and four ana-
lytes (TT4, TT3, FT3, and rT3) still exhibited 
non-Gaussian distribution following log transfor-
mation (Supplemental Table S1). Therefore, we 
recommend that the 2.5–97.5 percentile of the 
thyroid hormone values be used by laboratories 
routinely running this assay (Table 1). Due to the 
significant difference between a.m. and p.m. val-
ues, we recommended a.m. and p.m. reference 
intervals for FT4, TT3, FT3, and rT3 be reported 
based on time of sample collection (Table 1).
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Figure 1. Paired results between a.m. and p.m. thyroid hormone values for (a) TT4, (b) FT4, (c) TT3, (d) FT3, 
and (e) rT3. p values were calculated on the basis of Wilcoxon tests.
FT3, free triiodothyronine; FT4, free thyroxine; rT3, reverse T3; TT3, total triiodothyronine; TT4, total thyroxine.
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Discussion
Measurement of thyroid hormones in conjunc-
tion with TSH is used for the diagnosis and man-
agement of thyroid disorders. These analytes are 
routinely measured using automated immunoas-
say because the method is generally precise, 
quick, and does not require extensive training of 
personnel. However, immunoassays exhibit many 
limitations and often do not correlate with ultra-
filtration LC-MS/MS or the patient’s clinical 
presentation. For example, the one-step direct 
analog immunoassays are used most frequently to 
measure free thyroid hormones, but they are 
affected by changes in serum binding proteins.21 
Severe binding protein abnormalities, such as 
congenital TBG excess or deficiency,22,23 dys-
albuminemias,24,25 high TBGs in pregnancy, and 
low TBGs in patients with renal diseases and pro-
teinuria, as well as thyroid hormone autoantibod-
ies,26,27 can all cause interference in FT4 and FT3 
immunoassays. Immunoassays are also impacted 
by non-thyroid hormone related interferences 
from heterophile antibodies, including human 
anti-mouse antibodies (HAMA) and rheumatoid 
factor (RF), as well as interference related to the 
use of supplements such as biotin.1 All of these 
issues make harmonization a goal difficult to 
achieve.9
To overcome these limitations, we have devel-
oped two thyroid profile assays, one for the analy-
sis of TT4, TT3, and rT3 utilizing LC-MS/MS, 
and the other for the simultaneous analysis of 
FT4 and FT3 using ultrafiltration followed by 
LC-MS/MS.28 Compared with immunoassay, 
thyroid hormone results measured by LC-MS/
MS correlate better with patients’ clinical condi-
tions, and especially in patients with hypothyroid-
ism and hyperthyroidism.21,29,30 Thus, to date, 
this method is the preferred way to measure thy-
roid hormones accurately and precisely. However, 
accurate diagnosis should also be accompanied 
by establishment of reference intervals that ade-
quately control for diurnal fluctuation of thyroid 
hormones.31
According to our observations, one of the biggest 
diurnal changes was seen in FT3, and the ampli-
tude and timing of variability are consistent with 
published studies.13 With T3 being the biologi-
cally active hormone, assessment of its concentra-
tion while applying the appropriate reference 
range could provide valuable information, espe-
cially under pathophysiological conditions where 
serum FT3 levels are outside of the reference 
range whereas T4/TSH levels are still normal.15 
Some of these conditions include nonthyroidal 
illness, targeted inactivation of TRH gene, and 
caloric restriction.15,32
Our results suggest that FT4 has a significant 
uptrend at the end of the light phase (early even-
ing) compared with the beginning of the light 
phase (early morning), which follows the rhyth-
mic release of TSH as we have previously shown 
in this population.12 In addition, the higher con-
centration of steroids in the morning can inhibit 
TSH, whereas steroids reach the lowest levels in 
the evening, which results in an increase in 
TSH.30 At the same time, an opposite downward 
trend was observed for TT3 and FT3. It was pre-
viously shown that type II 5'-iodothyronine 
Table 1. Recommended reference intervals for thyroid hormones.
Percentile 2.5th 97.5th n
TT4 (ug/dl) 4.6 12.9 318
a.m. p.m.
Percentile 2.5th 97.5th 2.5th 97.5th n
FT4 (ng/dl) 1.18 2.88 1.22 3.13 146
TT3 (ng/dl) 62 202 65 192 159
FT3 (pg/ml) 1.8 7.6 1.7 6.1 141
rT3 (ng/dl) 4.0 195 5.4 192 159
FT3, free triiodothyronine; FT4, free thyroxine; rT3, reverse T3; TT3, total triiodothyronine; TT4, total thyroxine.
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deiodinase (5'D-II), the enzyme that catalyzes the 
intracellular conversion of T4 to T3 in the central 
nervous system, exhibited a significant daily vari-
ation, with a maximum in the early morning, and 
a minimum in the early afternoon.33 This change 
in 5'D-II activity could account for the opposite 
trends we observed in FT4 and FT3. On the 
other hand, type III 5-iodothyronine deiodinase 
(5D-III), the enzyme responsible for converting 
T4 to rT3, did not show diurnal variation, which 
is consistent with the similar upward trend in rT3 
and FT4.33
It should be noted that, in our study, FT3 and 
FT4 were separated from protein-bound hor-
mones by ultrafiltration at 37°C. Since ultrafiltra-
tion is temperature sensitive,34 for ultrafiltration 
performed at ambient temperature (25°C), the 
reference interval should be adjusted accordingly. 
It has been shown that results from LC-MS/MS 
following ultrafiltration at 37°C correlate well 
with those prepared by equilibrium dialysis,23 so 
our proposed reference intervals would poten-
tially apply to separation by equilibrium dialysis.
Although the importance of reference intervals 
has been highlighted here, our results might also 
be significant in advancing individualized care. 
For patients undergoing thyroid hormone replace-
ment therapy, for example, the detection of subtle 
changes in thyroid hormones is made possible 
through such technologies as LC-MS/MS.13,35 At 
the same time, this new set of time-specific refer-
ence intervals could better reflect the normal cir-
cadian rhythm of thyroid hormones, and its 
application would allow optimized medical care.13 
Studies have also shown that many patients diag-
nosed with subclinical hypothyroidism based on 
FT4 and FT3 immunoassay results had free thy-
roid hormone values below the reference interval 
when measured by LC-MS/MS.9,21,29 In this 
group of patients, for example, accurate measure-
ment of free thyroid hormones by LC-MS/MS 
and application of the appropriate reference range 
permit more effective clinical decision making 
and may shift medical intervention from the 
watch-and-wait strategy to more prompt 
treatment.9
In our study, we observed large variations in thy-
roid hormone concentrations among individuals 
(Figure 1), similar to those seen in previous refer-
ence interval studies.1,36 However, it could be 
argued that this high individuality can cause our 
proposed reference ranges to be insensitive to 
changes in test results that are significant for the 
individual. To overcome this large variation, a 
previous study has shown that subject-based ref-
erence intervals can be more informative than 
population-based reference intervals, and espe-
cially in diagnosing patients with subclinical thy-
roid disease.36 Our findings on average a.m. to 
p.m. change can be important when a subject-
based reference interval is implemented since 
diurnal difference is a major component of within-
individual biological variation.
In summary, this study establishes the time-spe-
cific reference intervals for LC-MS/MS-based 
measurements of five thyroid hormones. These 
reference intervals were implemented at the 
Clinical Center, NIH in June, 2019, and we 
strongly recommend other institutions consider 
using the far more specific LC-MS/MS approach 
than the regularly employed immunoassay meth-
ods, as the latter lack specificity and frequently 
could provide wrong clinical classification.
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